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Abstract. A model of hypertensive neuroretinopathy was developed on Wistar line rats with 
administration of non-selective NO-synthase blocker N-nitro-L-arginine methyl ester (L-NAME) 
in a dose 12.5 mg/kg within 28 days on the background of single increased intraocular pressure 
(IOP) to 110 mmHg. As a result of the interim evaluation of pathology simulation mode the most 
optimal was a model of hypertensive neuroretinopathy with 5-minute increased IOP at day 26 of 
the experiment on the background of L-NAME for further study of neuroretinoprotective 
properties of pharmacological agents. Changes formation of the retina and optic nerve disc 
(OND), observed in the hypertensive neuroretinopathy, confirmed by ophthalmoscopy, laser 
Doppler flowmetry (LDF), electroretinography (ERG), histological studies in a group of animals 
with the pathology modeling at the 29 day of experiment. 
Keywords: hypertensive neuroretinopathy, ophthalmoscopy, laser Doppler flowmetry, 
electroretinography. 
 
Introduction.  
Changes in the eye because of high blood 
pressure (BP) have a special place [1]. Hypertensive 
neuroretinopathy is a combination of signs of 
hypertensive retinopathy and changes in the optic 
disc (disc edema, increase in size, fuzzy edge, etc.). 
In the final stage, there may be an atrophy of the 
optic disc. Severe swelling of the optic disc – a sign 
of malignant hypertension stage.  
The retina is the only organ where blood vessels 
state can be directly evaluated by providing important 
information about the risk of hypertension [2]. 
Angiopathy of the retina of hypertensive type is 
correlated with a high risk of cardio – vascular 
diseases in general, but not included in the risk 
assessment tools. Currently abroad the research of 
hypertensive retinopathy as determinant of target 
organ damage in hypertension are actively conducted 
[3, 4, 5]. 
Speaking about the pathogenesis of hypertensive 
retinopathy, it should be noted three main factors: the 
restriction and increased vascular permeability, and 
arteriosclerosis. The changes occuring in the fundus 
are typical of chronic, acute or malignant 
hypertensive retinopathy. 
Against the background of hypertension the 
diameter of the arteries is reduced, cytoarchitectonics 
of bloodstream is disrupted. Due to vascular wall 
hypertrophy the vascular resistance is increased, their 
lumen is decreased which results in regional 
ischemia. 
Acute optic neuropathy is characterized by 
swelling of the optic disk, hemorrhages on the retinal 
surface in the peripapillary area due to the narrowing 
of the lumen of peripapillary choroidal vessels 
supplying the optic disc. Its ischemia leads to 
disruption of axoplasmatic current, which proves that 
this defeat is nothing but a form of anterior ischemic 
optic neuropathy. 
Patients with chronic hypertensive retinopathy 
do not show, as a rule, no complaints, they have no 
symptoms. Hypertensive retinopathy is detected by 
the presence of comorbidity: senile sclerosis of 
vessels and arterioles. The phase of vasoconstriction 
occurs due to diffuse spasm accompanied by 
increased blood pressure for some time, leading to an 
increase in retinal arteriolar tone. Sclerotic phase 
develops due to the increase in thickness or 
hypoplasia of the vascular wall, and hyaline 
degeneration, characterized by narrowing and 
arteriolar tortuosity [6]. 
All retinal changes occur due to high blood 
pressure, therefore primarily the treatment is directed 
to the hypertension therapy. Antihypertensives, 
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symptomatic treatment (angioprotectors, 
vasodilatators, retinoprotectors) are applied, which 
are nonspecific therapy and not always achieve the 
desired result. Therefore, effectiveness improving of 
pharmacological correction of hypertensive 
neuroretinopathy is an urgent task of the 
experimental and clinical pharmacology and 
ophthalmology. 
In connection with the above, it should be noted 
the relevance of developing an adequate model of 
hypertensive neuroretinopathy for further study of 
neuroretinoprotective properties of pharmacological 
agents using instrumental and histological methods of 
analysis. 
Objective: to develop an optimal model of 
hypertensive neuroretinopathy on Wistar rats to 
assess the neuroretinoprotective effects of 
pharmacological agents. 
Materials and methods.  
Experiments were carried out on male Wistar rats 
weighing 225-275 g. Rats were taken to study with no 
outward signs of disease, passed quarantine regime. 
Operations and other manipulations were 
performed on rats under general anesthesia by 
intraperitoneal (i/p) introducing an aqueous solution 
of chloral hydrate 300 mg/kg rat weight. 
Hypertensive neuroretinopathy simulation was 
performed by daily i/p L-NAME administration in a 
dose 12.5 mg/kg rat weight for 28 days [7] and the 
increase in IOP to 110 mmHg. [8] on day 26 of the 
experiment through the provision of mechanical 
pressure on the anterior chamber. 
After anesthesia by the i/p introduction of 
chloral hydrate solution at 26 day of the experiment 
the animal was fixed in position on the side, followed 
by an increase in IOP. 
To measure blood pressure in rats (tail) a 
system of non-invasive measurement of blood 
pressure for small animals NIBP200 was used in 
the complex Biopac-systems MP-150. 
To investigate the fundus of experimental 
animals a direct ophthalmoscopy was used on 29 day 
of the experiment (ophthalmoscope Bx a Neitz, 
Japan). To expand the pupil the eye drops Irifrin 
2.5% were used. Ophthalmoscope has been 
approached to the rat eye and we sent in it a beam of 
light from a distance of 0.5-2 cm to obtain a clear 
picture of the fundus image. In the dim image of the 
fundus we picked up the lens by turning the disc of 
ophthalmoscope, which gives crisp image details of 
the fundus. To zoom a lens Osher MaxField 78D 
model OI-78M has been used. 
For subsequent statistical processing the degree 
of change, detected during ophthalmoscopy, were 
ranking (Tab. 1). [7]. 
 
Table 1 
Methods of integrated semiquantitative evaluation  
of the fundus changes, detected during  
ophthalmoscopy (in grades) 
A set of attributes of fundus changes  Grades 
Optic disc is circular or oval shape and stands 
out from the fundus in pale – pink. The 
boundaries of the optic nerve disc are clear. It 
lies in the plane of the retina. From the middle 
of the optic nerve exit the central vessels of the 
retina. Blood vessels of the retina don`t have 
anastomoses. The veins and arteries are 
straightforward, caliber is uniform, not crimped. 
The general background is pink. 
0 
Angiopathy. Symptom Salus-Hun I. It is 
characterized by the presence of sclerosis of 
retinal vessels in fundus and "phenomenon of 
chiasm", which occurs due to indentation of 
artery at the site of chiasm with extended 
vein. Expansions of vein are on both sides of 
the chiasm. Symptom Guist – expansion and 
corkscrew curl of venules located around the 
macular; observed in hypertensive disease. 
1 
Angiosclerosis. Symptom of copper wire – 
yellow glow of the retinal arteries; sign of 
hypertensive retinal angiopathy. Symptom 
Salus-Hun II – the formation of bulges in 
arteries and veins chiasm. 
Symptom Salus-Hun III – the disappearance 
of the vein at the site of crossing due to the 
formation of the arcuate bend, sinking deep 
into the retinal tissue. Symptom of silver wire. 
Increased vascular permeability. 
2 
 
 
 
 
3 
Retinopathy. "Cotton" exudates. 
Hemorrhages. In the macular area may be 
deposits of hard exudates in a star shape. 
4 
Hypertensive neuroretinopathy. Severe 
discoloration of the optic nerve disc. Swelling 
of the optic disc and peripapillary retina. 
Multiple foci of hemorrhage and "cotton" 
exudate, indicates the growing ischemia. 
5 
 
Measuring of the microcirculation level in the 
rats retina was performed by LDF after examining 
the fundus. Registration is carried out by means of 
hardware and software Biopac-systems MP-150 and 
the needle-type sensor TSD-144 (USA) with 
AcqKnowledge 4.2 program. After animal anesthesia 
assessment of microcirculation level was carried out 
in ten points on the circumference of the eyeball, the 
recording duration of the microcirculation level 
readings at one point was 20 seconds. From the 
microcirculation level results at every point the 
average value has been calculated, which was taken 
as the indicator of the microcirculation level in the 
retina of the experimental animal. Value of 
microcirculation in the animal group was calculated 
as the average of the values obtained from each 
experimental animal in group [9]. 
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ERG was performed immediately after the 
registration of the microcirculation level. For this 
the animals were kept in the dark for 30 minutes 
[10], further the animals were anesthetized 
(chloral hydrate, 300 mg/kg, i/p) and fixed on the 
table, isolated from the electromagnetic radiation. 
Corneal silver electrode was placed on the cornea 
that has been soaked by saline solution for better 
contact, the reference needle electrode EL452 has 
been placed subcutaneously in the region of the 
skull, ground needle electrode EL450 has been 
placed subcutaneously in the base of the tail. 
Strobe flash of white light that is connected to the 
stimulator STM200 by company Biopac System, 
Inc. (USA) has been placed behind the back of the 
animal, ERG registration was carried out in 
response to a single stimulation. Evoked 
biopotentials were run at a frequency of 1-1000 
Hz, amplified, averaged and presented graphically 
on the screen using the Biopac-systems MP-150 
with a computer program AcqKnowledge 4.2 
(USA). ERG-recording was carried out for 0.5 
seconds in each rat in groups. To assess the 
degree of functional damage to the retina we 
evaluated the ratio of amplitudes of a- and b- 
wave of ERG – the coefficient b/a [11]. From ten 
values in each group were taken the average, which 
was added to the protocol. 
For histological examination the eyes were 
removed after the ERG, on 29 day of experiment, 
fully with adjacent structures and fixed by immersion 
method in 10% formalin solution. After fixation, eyes 
were cut into two parts in the meridian direction 
substantially through the center and both halves 
embedded in paraffin according to standard 
procedures. Also, the serial sections in a meridian 
direction were made 5-7 mm thick, which were 
stained with hematoxylin and eosin. Histological 
processing steps performed using the «Leica» 
equipment company (Germany). For microscopic 
examination and archiving the finished 
micropreparations were scanned using a computer 
image archiving and analysis system "Mirax Desk". 
Image analysis and morphometry performed using 
«Pannoramic Viewer» program 1.15.4. In a strictly 
perpendicular direction the thickness of the retinal 
layers were measured with an accuracy of hundredths 
of a micrometer. 5 representative areas of each 
animal, free from processing artifacts, were 
measured. Quantitative data were recorded in the MS 
Excel spreadsheets. 
For all data the descriptive statistics were used: 
data are checked for normal distribution. Distribution 
type was determined by using the criterion of Shapiro-
Wilk. In case of normal distribution the average value 
(M) and standard error of the mean (m) were calculated. 
In cases of abnormal distribution the median (Me) and 
the quartile range (QR) were calculated. 
Between-group differences were analyzed by 
parametric (t-Student criterion) or non-parametric 
(Mann-Whitney test) methods, depending on the type 
of distribution. Differences were determined at 0.05 
significance level. Statistical analyzes were 
performed by using Statistica 10.0 software. 
The main part. 
We have proposed a modification of 
hypertensive neuroretinopathy model on Wistar line 
male rats, in which increased IOP is carried out by 
mechanical pressure (110 mm Hg) to the front 
chamber of the eye on 26 day of the experiment on 
the background of daily administration of L-NAME 
in a dose 12.5 mg/kg within 28 days. 
At the heart of pathogenesis is the development 
of hypertension in rats to 29 day of the experiment 
(SBP 204.8 mmHg, DBP 164.2 mmHg in a group 
with pathology; SBP 139.2 mmHg, DBP 104.2 
mmHg in the intact group, p<0.05). 
The confirmation of the formation of 
hypertensive neuroretinopathy on 29 day of the 
experiment were the results of ophthalmoscopy, 
LDF, ERG and histological studies. 
The evaluation of the interim regime of 
increased IOP was performed. To find the optimal 
time of IOP increase to 110 mmHg the experiment 
included 5 groups of animals: 
the first (n = 10) – intact animals, 
the second (n = 10) – with the introduction of L-
NAME within 28 days, 
the third (n = 10) – with the introduction of  
L-NAME within 28 days + increased IOP within 2 min, 
the fourth (n = 10) – with the introduction of L-
NAME within 28 days + increased IOP within 5 min, 
the fifth (n = 10) – with the introduction of  
L-NAME within 28 days + increased IOP within  
10 min. 
After the IOP increase after 72 hours of 
reperfusion [8], on 29 day of the experiment, the 
ophthalmoscopy, measurement of the microcirculation 
in the retina by LDF, determination of the functional 
condition of the retina by ERG, enucleation of eyes for 
histological studies were performed. 
Results. 
In accordance with the study design, the 
duration of a single IOP increasing in hypertensive 
neuroretinopathy simulation with L-NAME 
administration was 2.5 and 10 min, followed by 
reperfusion period lasting 72 hours. 
In accordance with the protocol, after the IOP 
increase after 72 h of reperfusion (29 day of 
experiment) animal anesthesia was performed 
(chloral hydrate solution i/p 300 mg/kg). Then 
ophthalmoscopy, assessment of the microcirculation 
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level in the retina, retinal electrophysiological state 
and taking the material for histological studies were 
performed. 
Example of ophthalmoscopy on intact animal is 
shown in fig. 1. 
 
 
Figure 1. Example of ophthalmoscopy on intact Wistar rat. Optic disc is circular or oval shape and stands out from the fundus 
in pale – pink. The boundaries of the optic nerve disc are clear. It lies in the plane of the retina. From the middle of the optic 
nerve exit the central vessels of the retina. Blood vessels of the retina don`t have anastomoses. The veins and arteries are 
straightforward, caliber is uniform, not crimped. The general background is pink 
 
In the group with daily administration of L-
NAME in a dose 12.5 mg/kg on day 29 of the 
experiment the retinal angiopathy of hypertensive 
type was observed. Ophthalmoscopic picture: optic 
disc is circular or oval shape and stands out from the 
fundus in pink. The boundaries of the optic nerve 
disc are clear. Veins are congested, full-blooded, 
crimped at the periphery. Arteries are narrowed, 
slightly crimped. Retina is palely (ischemic). 
Symptom Salus-Hun I. 
Ophthalmoscopy example on rat in pathology 
modeling on the background of L-NAME 
administration and single IOP increase within 2 min 
is shown in fig. 2. We observed a pattern similar to 
retinopathy on the background of arterial 
hypertension without lesions of the optic disk. 
 
 
Figure 2. Example of ophthalmoscopy on Wistar rat with pathology simulation on the background of L-NAME and a single 
IOP increase within 2 min. Optic disc is round or oval shape and stands out from the fundus of the eye in pink. The boundaries 
of the OND are clear. It lies in the plane of the retina. There are pockets of "cotton" exudate (arrow + CE). Viens are 
congested. Arteries are narrowed. Vessel caliber is uneven. Retina is palely (ischemic). Symptom Salus-Hun I (arrow + S I) 
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Figure 3. Examples of ophthalmoscopy on Wistar rats with pathology simulation on the background of L-NAME and a single 
IOP increase within 5 min. Optic disc is edematous, increased in size, edema extends to the retina. A slight blurring boundaries 
of OND. There are pockets of "cotton" exudate (arrow + CE), indicating the growing ischemia. Viens are congested, crimped 
at the periphery. Arteries are narrowed. Vessel caliber is uneven. Retina is palely (ischemic). Symptom Salus-Hun I (arrow + S 
I). In rare cases, the solid exudate deposits were observed (arrow + SE) 
 
Examples of ophthalmoscopy on Wistar rats 
with pathology simulation on the background of  
L-NAME and a single IOP increase within 5 min are 
shown in fig. 3. We observed a pattern similar to 
hypertensive neuroretinopathy. 
In the group with pathology simulation on the 
background of L-NAME and single IOP increase within 
10 min irreversible changes, presumably, typical for 
neovascular glaucoma were observed (fig. 4). 
 
S I 
CE 
CE 
SE 
CE 
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Figure 4. Pathological changes in the eye on the 
background of L-NAME administration 
 and single IOP increase within 10 min 
 
 
Thus, the results of fundus research during 
ophthalmoscopy on experimental animals have found 
that the optimal model of pathology was with single 
5-minute IOP increase to 110 mmHg on day 26 of the 
experiment on the background of daily i/p L-NAME 
administration in a dose 12.5 mg/kg within 28 days 
for the study of the neuroretinoprotective properties 
of pharmacological agents. 
Integral evaluation showed, respectively, 0 and 
4-5 points for intact rats and rats with hypertensive 
neuroretinopathy (tab. 2). 
Table 2 
Integral assessment of fundus changes, detected during 
ophthalmoscopy (scores 0-5; n = 10) 
Experimental groups 
Integral 
assessment in 
scores 
Intact 0 
With L-NAME introduction, 12,5 
mg/kg within 28 days 
3* 
With L-NAME introduction, 12,5 
mg/kg within 28 days + IOP increase 
within 2 min 
3-4* 
With L-NAME introduction, 12,5 
mg/kg within 28 days + IOP 
increase within 5 min 
4-5* 
With L-NAME introduction, 12,5 
mg/kg within 28 days + IOP increase 
within 10 min 
>5* 
After modeling of hypertensive 
neuroretinopathy on rats on 29 day of the experiment 
we observed the deterioration of retinal blood flow, 
which is associated with the development of the 
pathological cascade of morphological and functional 
changes in the retina. 
The level of the retinal microcirculation of intact 
animals was 743.0 ± 20.9 p.u. In the group with  
L-NAME administration after disease modeling on 
29 day microcirculation level was decreased to  
431,4 ± 13,8 p.u., which was significantly different 
from the values of intact animals (p<0.05). In the 
group with L-NAME administration within 28 days 
and an IOP increase within 2 min this indicator was 
420,7 ± 10,5 p.u. (p<0.05 compared with the group of 
intact animals). In the group with L-NAME 
administration within 28 days and an IOP increase 
within 5 min microcirculatory level was  
417.2 ± 13.1 p.u. (p<0.05 compared with the group of 
intact animals), which is less than the value in the 
group of intact animals by 44% and confirms the 
formation of retinal ischemia in the hypertensive 
neuroretinopathy simulation. In the group with  
L-NAME administration and an IOP increase within 
10 min the rate was 804.1 ± 15.0 p.u. (p<0.05 
compared with the group of intact animals). The 
increase in regional blood flow is attributed to 
compensatory pathological neoangiogenesis and later 
development of neovascular glaucoma. 
Based on these results, it should be noted that 
the duration of ischemic episode with an IOP 
increase on the background of L-NAME 
administration significantly affects to the level of 
retinal microcirculation after 72 h of reperfusion. 
Violations of local hemodynamics and formation 
of pathological changes in the optic disk led to 
changes in retinal electrophysiological state. To 
assess the severity of the functional changes in the 
retina we used the ratio b-wave amplitude to the 
amplitude of a wave of the ERG – the coefficient b/a 
[11]. After the measuring of the microcirculation 
level in the retina the ERG on evoked potential was 
performed. The data obtained are presented in tab. 3. 
 
Note. * – p<0.05 compared with the group of intact animals 
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Table 3 
The results of evaluation of retinal electrophysiological state on day 29  
of the experiment (M ± m; n = 10), r.u. 
Experimental groups b/a 
Intact 2.6±0.07 
With L-NAME introduction, 12.5 mg/kg within 28 days 2.2±0.09* 
With L-NAME introduction, 12.5 mg/kg within 28 days + IOP increase within 2 min 2.1±0.06* 
With L-NAME introduction, 12.5 mg/kg within 28 days + IOP increase within 5 min 1.9±0.08* 
With L-NAME introduction, 12.5 mg/kg within 28 days + IOP increase within 10 min 1.1±0.05* 
Note. * – p<0.05 compared with the group of intact animals 
 
During the ERG found that the ratio b/a in the 
group of intact animals was 2.6 ± 0.07 r.u. After 
pathology modeling, on 29 day of the experiment, 
in group with L-NAME administration the ratio b/a 
was 2.2 ± 0.09 r.u., which was significantly 
different from the values of intact animals (p<0.05) 
and smaller than value in group of intact animals 
by 15%. In the group with L-NAME administration 
within 28 days and an IOP increase within 2 min 
the rate was 2.1 ± 0.06 r.u. (p<0.05 compared with 
the group of intact animals), which is less than in 
the group of intact animals by 19%. In the group 
with administration of L-NAME within 28 days 
and an IOP increase within 5 minutes b/a was 1.9 ± 
0.08 r.u. (p<0.05 compared with the group of intact 
animals), which is less than the value of intact 
animals by 27%. In the group with administration 
of L-NAME and an IOP increase within 10 min the 
rate was 1.1 ± 0.05 r.u. (p<0.05 compared with the 
group of intact animals), which is less than in the 
group of intact animals by 58%. 
Based on these data, we can conclude that the 
modeling of pathology causes a disturbance of the 
electrophysiological state of inner retinal layers 
due to violations of the retinal blood flow and the 
formation of chronic ischemia. 
Data obtained during ophthalmoscopy, an 
integrated evaluation of the fundus changes, LDF 
and ERG in experimental groups, lead to the 
conclusion that the most optimal is the pathology 
model (of hypertensive neuroretinopathy) on the 
background of introduction of non-selective 
blocker of NO-synthase L-NAME in a dose of 12.5 
mg/kg within 28 days and a single elevated IOP to 
110 mmHg within 5 min on 26 day of the 
experiment for further research of 
neuroretinoprotective properties of 
pharmacological agents. 
Based on the foregoing, the rats retina of the 
group with the introduction of L-NAME in a dose 
of 12.5 mg/kg within 28 days and an IOP increase 
within 5 min were subject to further histological 
examination. Histological examination revealed 
significant qualitative changes in all layers of the 
retina. The overall structure of the layers is 
loosened. During histological processing there 
were easily detached retina from the choroid, and 
the appearance of slit-like defects between the 
layers, simulating the swelling. In the 
photoreceptor layer the outer segments of rods and 
cones are less compact than normal, among them 
are found small slit and spheroid intervals (fig. 5 
B, 6 A). 
In the outer nuclear layer the dense 
arrangement of nuclei of photoreceptor cells, 
characteristic of norm, is lost, which indicates the 
decompaction of perikaryons location of 
photoreceptor cells (fig. 5 B, 6). Glial outer 
limiting membrane in normal tissue specimens is 
not detected (fig.6 A). Changes in the blood 
vessels of the microvasculature are also identified 
in the form of capillary stasis and formation of 
hyaline thrombus in small vessels (Fig. 6 B).
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Figure 5. Histology of the retina in the group with experimental hypertensive neuroretinopathy:  
loosening of the layers structure (A), decompaction of location of the outer segments  
of rods and cones in the photoreceptor layer (Ph), decompaction of perikaryons loc ation  
of photoreceptor cells in the outer nuclear layer (B)  
Hematoxylin and eosin. Microphoto. x100 (A), x200 (B) 
B 
Ph 
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Figure 6. Changes in retinal layers in the group with experimental hypertensive neuroretinopathy:  
A – structure decompaction of photoreceptor layer, spheroid and slit -like spaces between the outer segments  
of the rods and cones, the disorganization of the outer glial limiting membrane (its location indicated by an asterisk), 
B – loose structure of the outer nuclear layer, hyaline thrombus in the small blood vessel is indicated by the arrow  
Hematoxylin and eosin. Microphoto. x400 
 
 
Until heavy changes are identified in the inner 
retinal layers. The inner nuclear layer is loosened, 
slotted bundles (fig. 7 A). The inner retinal layer, as 
well as outer, has loosened spongy appearance, which 
may reflect the relationship disruption of  rames of 
ganglion and associative retinal neurons. Ganglionic 
layer neurons are exposed to severe changes in a 
hydropic dystrophy, chromatolysis, nuclear pinosis 
(fig 7, fig. 10), cytolytic changes are detected (fig. 8 
B, fig. 11). The inner layers that formed by retinal 
neuronal processes (inner retinal layer and the nerve 
fibers) have spongy form (fig. 7, 8, 10), which may 
be indicative of axonal damage and disrupt of 
synaptic connections. 
Described neuronal damages are occurring on 
the background of expressed microcirculatory 
disorders with severe venous congestion (fig. 7-9), 
arterioles damage with plasma impregnation of their 
walls (fig. 8 A). 
 
 
B 
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Figure 7. Changes in retinal layers in the group with experimental hypertensive neuroretinopathy:  
A – loose structure. The bundles in the inner nuclear layer, B – loosened structure of the inner retinal layer,  
expressed pericellular swelling in the ganglion layer (arrow), C – hydropic degeneration of ganglion neurons,  
capillary stasis with red blood cells in the form of "monetary pillar", the layer  
of nerve fibers (right part of microphoto) with spongiform changes. 
Hematoxylin and eosin. Microphoto. x200 
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Figure 8. Vessels of retinal microcirculatory bed in the 
experimental group with hypertensive neuroretinopathy:  
A – plasmatic impregnation phenomenon in the wall of 
arterioles, B – full-blooded small vein, neuron fragments  
of ganglion layer with signs of cytolysis (arrow). 
Hematoxylin and eosin. Microphoto. x200 
 
Figure 9. Severe venous congestion in the inner layers of 
the retina in the group with experimental hypertensive 
neuroretinopathy. 
Hematoxylin and eosin. Microphoto. x100 
 
 
 
 
Figure 10. Changes in the ganglion layer and retinal nerve fiber layer in the group with experimental hypertensive 
neuroretinopathy: 
  A – hydropic dystrophy, cytolytic changes of ganglion neurons, B – chromatolysis, karyopyknosis in the ganglion neurons, 
spongiform changes in the nerve fiber layer. Hematoxylin and eosin. Microphoto. x200
B 
B 
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Figure 11. Heavy neuronal changes in the retinal ganglion 
layer in the group with experimental hypertensive 
neuroretinopathy: hydropic degeneration of neurons up to 
the balloon and total cytolysis, the arrow – a neuron with a 
total chromatolysis and karyopyknosis. Hematoxylin and 
eosin. Microphoto. x200 
 
 
As a result, the proposed model of hypertensive 
neuroretinopathy is characterized by: 
 severe vascular changes of hypertensive type 
in the retina, attributes of ischemic injury and 
pathological changes of the optic disc (4-5 points, 
p<0.05 compared with the group of intact animals) 
during ophthalmoscopy and integral evaluation of the 
fundus changes; 
 statistically significant difference between 
values of the microcirculation level in the retina of 
rats with pathology from values in the intact group on 
day 29 of the experiment; 
 significant reduction of coefficient b/a of 
ERG after the pathology simulation on 29 day of the 
experiment in comparison with the value in the group 
of intact animals. 
 severe pathological changes of the inner 
layers of the retina revealed by histological 
examination. 
Discussion. 
Cardiovascular diseases are one of the main 
causes of death, and hypertension – the most 
common risk factor. Since the blood circulation in the 
retina are anatomically and physiologically similar to 
coronary and cerebral circulation, ophthalmologists 
received a "window" for the study of 
microcirculation. Idiopathic (primary) and malignant 
hypertension can become a cause of retinopathy. The 
etiology of idiopathic hypertension is not known, it is 
diagnosed when blood pressure levels in the arteries 
during systole >140 mmHg and diastolic >90 mmHg. 
Malignant hypertension is much rarer, it is diagnosed 
in 1% of patients with hypertension. 
Hypertensive neuroretinopathy is more likely to 
develop in the late period of hypertensive disease and 
usually is a poor prognostic sign. It is characterized 
not only by changes in the blood vessels and retinal 
tissue, and involvement in the process of the optic 
disk, which becomes swollen, increased in size, 
swelling extends to the retina. Ophthalmoscopic 
picture is similar to the symptoms of stagnant disc, 
but unlike it marked a dramatic violation of color 
vision, decreased visual function: the decline of 
central vision and the narrowing of the field of view. 
At the end of neuroretinopathy an atrophy of the 
optic nerve may develop. 
In malignant hypertension sclerotic processes 
are developing very quickly. Changes occuring in the 
fundus are typical for hypertensive retinopathy, 
choriopathy and optic neuropathy. Transudate 
deposition in the retinal layers of white oval due to 
the deposition of macromolecules during the 
arterioles. Moreover, there is the presence of 
structures in the form of "cotton lumps" and 
microaneurysms of capillaries obliteration zone. 
Optic neuropathy is characterized by swelling of 
the optic disk, hemorrhages on the retinal surface in 
the peripapillary area due to the narrowing of the 
lumen of peripapillary choroidal vessels supplying 
the optic disc. Its ischemia leads to disruption of 
axoplasmatic current, which proves that this defeat is 
nothing but a form of anterior ischemic optic 
neuropathy [6]. 
The main factors in the development of retinal 
angiopathy of hypertensive type are disorders of 
common hemodynamics, local changes in the vessel 
walls. From local changes are the most important 
violations of the vascular endothelium [12]. 
The search of new methods of 
neuroretinoprotection for possible reduction of the 
damaging effect of ischemia, formed in hypertensive 
neuroretinopathy is an urgent task of pharmacology 
and ophthalmology. Segment of drugs for the 
treatment of vascular diseases of the eye as 
complications of hypertension is expedient to expand 
due to an increase in morbidity and lack of funds for 
targeted correction of ischemic lesions of the eye 
vessels [13]. 
Based on the fact that electrophysiological 
studies often have a decisive importance in the early 
and differential diagnosis of retinal disorders [14], to 
study the correction of functional changes in the 
retina, researcher must conduct a comprehensive 
analysis, including ophthalmoscopic, 
electroretinography, microcirculation research. 
Analysis of the dynamics of retinal electrogenesis 
allows to evaluate the nature and topography of 
retinal disorders, as well as to identify the most labile 
hypoxic retinal structure, their reaction to the 
correction by the  medications. 
The foregoing predetermined the need to 
develop and systematize the methodological 
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approaches to the assessment of the functional state 
of the retina and the subsequent optimization of 
correction of hypertensive neuroretinopathy. The 
studies conducted in our experiments on Wistar rats 
had developed a set of methodological approaches to 
assess the functional status of the retina, including 
instrumental methods of analysis (ophthalmoscopy, 
LDF, ERG) and histological studies of retinal layers. 
The first step in exploring the possibility of 
correction of hypertensive neuroretinopathy was the 
development of its models on the laboratory Wistar 
rats. To do this, ophthalmoscopy, integrated semi-
quantitative assessment of fundus changes are 
performed, the level of the retinal microcirculation 
and its electrophysiological state are evaluated, then 
the histological studies of retinal layers were held. 
As a result of temporary mode evaluation of 
pathology simulation the most optimal was a model 
of hypertensive neuroretinopathy with administration 
of nonselective ΝΟ-synthase inhibitor L-NAME in a 
dose 12.5 mg/kg within 28 days and a single IOP 
increase up to 110 mmHg within 5 min on 26 day of 
experiment for  creation of ischemia episode, 
followed by a reperfusion lasting for 72 hours. 
It should be noted that the proposed method 
complex of functional changes associated with the 
development of hypertensive neuroretinopathy allows 
to evaluate sufficiently objectively the 
neuroretinoprotective effects of pharmacological agents. 
Conclusion.  
The study developed a model of hypertensive 
neuroretinopathy on rats of Wistar line, integrated 
semi-quantitative assessment of the fundus were held, 
the level of microcirculation, retinal 
electrophysiological status, histology retinal layers 
were assessed, that allowing to fully appreciate the 
formation of the changes in the modeling of 
pathology. 
This model makes possible to evaluate 
sufficiently objectively the retinotropic effects of 
pharmacological agents. 
Thus, the prospects become apparent to optimize 
the pharmacotherapy of conditions accompanied by 
retinal ischemia, which are closely linked with the task 
of forming the methodology of the study of 
antiischemic activity of pharmacologic agents based on 
an adequate assessment of the functional condition of 
the retina by instrumental methods of histological 
studies. 
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